The trademark application Frehemgo was filed by Novo Nordisk Health Care AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on February 21, 2022, and it was registered by office on May 31, 2022 without any oppositions.
The application was filed in Danish (English was selected as the second language).